Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysisXi Wu, Shengying Qin, Guoyin Feng et al.|Parkinsonism & Related Disorders|2012Cited by 35
Pharmacogenomics can improve antipsychotic treatment in schizophreniaQingqing Xu, Shengying Qin, Xi Wu et al.|Frontiers of Medicine|2013Cited by 30
Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han PopulationRan Huo, Shengying Qin, Kefu Tang et al.|PLoS ONE|2012Cited by 20
A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China – A Basis for Personalized TherapyZhenqiang Wu, Shengying Qin, Xiaoqing Zhang et al.|PLoS ONE|2013Cited by 12
Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 CellsHuihui Du, Shengying Qin, Zhiyun Wei et al.|Frontiers in Pharmacology|2016Cited by 11